MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20210163536A1
SERIAL NO

17166756

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IPSEN PHARMA SAS65 QUAI GEORGES GORSE F-92100 BOULOGNE-BILLANCOURT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Comstock, Jeanne Mary West Boylston, US 10 37
Deoliveira, Daniel B Bellingham, US 10 32
Dong, Zheng Xin Holliston, US 114 936

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation